This brand name is authorized in Austria, Brazil, Poland, Turkey
The drug PROSTAVASIN contains one active pharmaceutical ingredient (API):
|
1
Alprostadil alfadex
UNII F5TD010360 - ALPROSTADIL
|
|
Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C01EA01 | Alprostadil | C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EA Prostaglandins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 552919120086617 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100088173 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699587263889, 8699587263896 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
